Naturalendo Tech Co Ltd (168330) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.037x

Based on the latest financial reports, Naturalendo Tech Co Ltd (168330) has a cash flow conversion efficiency ratio of 0.037x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩853.52 Million ≈ $578.42K USD) by net assets (₩23.18 Billion ≈ $15.71 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 168330 equity to assets ratio to measure how much of total assets are equity-financed.

Naturalendo Tech Co Ltd - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Naturalendo Tech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Naturalendo Tech Co Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.

Naturalendo Tech Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Naturalendo Tech Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Salter Brothers Emerging Companies Ltd AU:SB2	0.018x
WT Financial Group Ltd AU:WTL	0.125x
Green Cross Medical Science Corporation KQ:142280	-0.003x
Ruanyun Edai Technology Inc. Ordinary shares NASDAQ:RYET	-0.043x
EYG Gayrimenkul Yatirim Ortakligi A.S. IS:EYGYO	0.020x
Halcyon Technology Public Company Limited BK:HTECH	0.022x
Hotel Sahid Jaya Tbk JK:SHID	-0.006x
Aeries Technology Inc. NASDAQ:AERT	-0.778x

Annual Cash Flow Conversion Efficiency for Naturalendo Tech Co Ltd (2014–2025)

The table below shows the annual cash flow conversion efficiency of Naturalendo Tech Co Ltd from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Naturalendo Tech Co Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩23.25 Billion ≈ $15.75 Million	₩-5.66 Billion ≈ $-3.84 Million	-0.243x	-206.18%
2024-12-31	₩26.87 Billion ≈ $18.21 Million	₩-2.14 Billion ≈ $-1.45 Million	-0.080x	+27.90%
2023-12-31	₩30.94 Billion ≈ $20.97 Million	₩-3.41 Billion ≈ $-2.31 Million	-0.110x	+11.18%
2022-12-31	₩36.58 Billion ≈ $24.79 Million	₩-4.54 Billion ≈ $-3.08 Million	-0.124x	+44.42%
2018-12-31	₩36.49 Billion ≈ $24.73 Million	₩-8.15 Billion ≈ $-5.52 Million	-0.223x	-62.67%
2017-12-31	₩54.72 Billion ≈ $37.08 Million	₩-7.52 Billion ≈ $-5.09 Million	-0.137x	+64.47%
2016-12-31	₩47.30 Billion ≈ $32.05 Million	₩-18.28 Billion ≈ $-12.39 Million	-0.387x	-165.39%
2015-12-31	₩50.46 Billion ≈ $34.20 Million	₩-7.35 Billion ≈ $-4.98 Million	-0.146x	-200.14%
2014-12-31	₩71.65 Billion ≈ $48.55 Million	₩10.42 Billion ≈ $7.06 Million	0.145x	--

About Naturalendo Tech Co Ltd

KQ:168330 Korea Biotechnology

Market Cap

$38.73 Million

₩57.15 Billion KRW

Market Cap Rank

#22832 Global

#1468 in Korea

Share Price

₩1810.00

Change (1 day)

+4.14%

52-Week Range

₩1738.00 - ₩1919.00

All Time High

₩1919.00